ANVISA registration 81357320145Active

RETINOL BINDING PROTEIN

Name: RETINOL BINDING PROTEIN — ANVISA registration 81357320145
Creator: TRIMERO DIAGNOSTICS, S.L.
Keywords: RETINOL BINDING PROTEIN, RETINOL LIGADO A PROTEÍNA, 3diag U-RBP - OPT Kit, 81357320145, Risk Class II, ANVISA registration

ANVISA Registration Number: 81357320145THE BINDING SITE BRASIL COMERCIO DE PRODUTOS PARA LABORATORIO LTDATRIMERO DIAGNOSTICS, S.L.Risk Class II

Verified

Device names

Technical name: RETINOL BINDING PROTEIN
Commercial name: 3diag U-RBP - OPT Kit
Risk class: Class II

Registration details

Registration Number: 81357320145
Process Number: 25351023991202514
CNPJ: 23119193000108

Company information

Registration Holder: THE BINDING SITE BRASIL COMERCIO DE PRODUTOS PARA LABORATORIO LTDA
Manufacturer: TRIMERO DIAGNOSTICS, S.L.
Manufacturing Country: Spain

Dates and status

Publication Date: Mar 17, 2025
Validity: VIGENTE
Last Updated: 08/18/2026 19:00:00

About this record

Access comprehensive regulatory information for RETINOL BINDING PROTEIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81357320145 and manufactured by TRIMERO DIAGNOSTICS, S.L.. The registration is held by THE BINDING SITE BRASIL COMERCIO DE PRODUTOS PARA LABORATORIO LTDA with validity until currently active (VIGENTE).

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.